prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumB, FINAL DIAGNOSIS: PART 1: LYMPH NODE, SENTINEL LYMPH NODE #1, LEFT AXILLA, EXCISIONAL BIOPSY -. A. AXILLARY SENTINEL LYMPH NODE #1 WITH FOCAL METASTATIC ADENOCARCINOMA (1/1);. B. METASTATIC FOCUS MEASURES 0.8 CM IN MAXIMUM DIAMETER. C. NO EXTRANODAL EXTENSION IS IDENTIFIED. PART 2: BREAST, LEFT_NEEDL LOCALIZED SEGMENTAL MASTECTOMY AT 12 O'CLOCK -. A. INVASIVE DUCTAL CARCINOMA. B. NOTTINGHAM GRADE III (TUBÜLE FORMATION 3/3, NUCLEAR GRADE 3/3, MITOTIC ACTIVITY 2/3;. TOTAL SCORE 8/9). C. MULTIFOCAL INVASIVE TUMOR RANGES IN SIZE FROM 0.2 CM TO 1.6 CM IN LARGEST DIMENSION. (GROSS AND MICROSCOPIC MEASUREMENTS). D. DUCTAL CARCINOMA IN SITU, NUCLEAR GRADE 2, SOLID TYPE WITH COMEDO NECROSIS, PRESENT. ADMIXED WITH AND AWAY FROM TUMOR AND ACCOUNTS TO 30% OF TOTAL TUMOR VOLUME. E. LYMPHOVASCULAR INVASION IS IDENTIFIED. F. RESECTION MARGINS ARE NEGATIVE FOR CARCINOMA. G. TUMOR TESTED ER POSITIVE, PR POSITIVE, HER-2/NEU NEGATIVE (SCORE 1+). H. FIBROCYS 11C CHANGE, COLUMNAR CELL CHANGE, ADENOSIS AND FIBROSIS. I. BIOPSY SITE CHANGES.

expanded version (tokens=811) : 
 Here's a summary of the relevant findings from the breast pathology report:

- Histological classification: Invasive ductal carcinoma, with a subtype of LumB.
- Subtype: LumB.
- Description of necrosis: There is comedo necrosis present in the ductal carcinoma in situ component of the tumor.
- Tumor infiltrating lymphocytes: There is no mention of this in the report.
- Histological grade: Nottingham grade III, with tubule formation score of 3/3, nuclear grade of 3/3, and mitotic activity score of 2/3 (total score of 8/9).
- Nuclear grade: Nuclear grade is mentioned as 3/3 for the invasive ductal carcinoma and 2 for the ductal carcinoma in situ component.
- Lymphovascular invasion: This is identified in the report.
- Calcification: There is no mention of calcification in the report.
- Receptor status: The tumor is ER-positive and PR-positive, and HER-2/neu-negative (score 1+).
- IHC and other ancillary testing: No other ancillary testing is mentioned, but needle localized segmental mastectomy was performed on the left breast.

Additionally, the report notes multifocal invasive tumor ranging from 0.2 cm to 1.6 cm in largest dimension, with ductal carcinoma in situ accounting for 30% of the total tumor volume. Resection margins are negative for carcinoma. Fibroc

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1005) : 
 The pathology report of a needle-localized segmental mastectomy on the left breast shows invasive ductal carcinoma, with a LumB subtype. Tubule formation score is 3/3, nuclear grade is 3/3, and mitotic activity score is 2/3 – totaling 8/9. Lymphovascular invasion is identified. ER and PR are positive, while HER-2/neu has a score of 1+. Ductal carcinoma in situ with comedo necrosis is present and accounts for 30% of tumor volume. Tumor margins are negative. Fibrocystic change, columnar cell change, adenosine & fibrosis were found, as well as biopsy site changes.

